• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Optimizing Treatment Sequencing in Advanced Colorectal Cancer

Opinion
Video

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + tipiracil ± bevacizumab, and explore the further research needed to understand optimal sequencing of these treatments better.

Video content above is prompted by the following:

  • What additional factors do you consider when determining the most effective sequence of these therapies (fruquintinib, regorafenib, trifluridine + tipiracil ± bevacizumab)?
  • What further research is needed to understand optimal sequencing of these therapies better?

Related Videos
1 expert is featured in this series.
3 experts are featured in this series.
2 experts in this video
1 expert is featured in this series.
© 2025 MJH Life Sciences
AJMC®
All rights reserved.